152 related articles for article (PubMed ID: 33942928)
1. The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors.
Gupta AM; Bajpai M
J Clin Apher; 2021 Aug; 36(4):621-627. PubMed ID: 33942928
[TBL] [Abstract][Full Text] [Related]
2. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
Gupta AM; Bajpai M
J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
[TBL] [Abstract][Full Text] [Related]
3. Safety and frequency of whole blood donations from elderly donors.
Müller-Steinhardt M; Müller-Kuller T; Weiss C; Menzel D; Wiesneth M; Seifried E; Klüter H
Vox Sang; 2012 Feb; 102(2):134-9. PubMed ID: 21806633
[TBL] [Abstract][Full Text] [Related]
4. The relative safety of automated two-unit red blood cell procedures and manual whole-blood collection in young donors.
Benjamin RJ; Dy BA; Kennedy JM; Notari EP; Eder AF
Transfusion; 2009 Sep; 49(9):1874-83. PubMed ID: 19538429
[TBL] [Abstract][Full Text] [Related]
5. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
6. Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study.
Zhao J; Gabriel E; Norda R; Höglund P; Baden L; Diedrich BA; Marits P; Enoksson SL; Gansner JM; Kaufman R; Dickman PW; Edgren G
Transfusion; 2021 Feb; 61(2):464-473. PubMed ID: 33186486
[TBL] [Abstract][Full Text] [Related]
7. Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.
Pitman JP; Basavaraju SV; Shiraishi RW; Wilkinson R; von Finckenstein B; Lowrance DW; Marfin AA; Postma M; Mataranyika M; Smit Sibinga CT
Transfusion; 2015 Jul; 55(7):1685-92. PubMed ID: 25727921
[TBL] [Abstract][Full Text] [Related]
8. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.
Daurat A; Roger C; Gris J; Daurat G; Feissel M; Le Manach Y; Lefrant J; Muller L
Transfusion; 2016 Jun; 56(6):1295-303. PubMed ID: 26814984
[TBL] [Abstract][Full Text] [Related]
9. Delayed adverse reactions in whole blood donors: Importance of active surveillance in identifying the missing gaps in the donor safety.
Gupta AM; Bajpai M
Indian J Med Res; 2023 Jan; 157(1):30-36. PubMed ID: 37040224
[TBL] [Abstract][Full Text] [Related]
10. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
Williams D; Rao M; Carey P
J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
[TBL] [Abstract][Full Text] [Related]
11. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
[TBL] [Abstract][Full Text] [Related]
12. Total platelet donation count and donation frequency are determinants of plateletpheresis-associated lymphopenia.
Thuer L; Brosig A; Hutchinson JA; Hähnel V; Offner R; Burkhardt R; Ahrens N
Transfusion; 2021 Nov; 61(11):3161-3173. PubMed ID: 34545947
[TBL] [Abstract][Full Text] [Related]
13. Demographics of apheresis platelet donors in five blood centers in China.
Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Liu J; Wright DJ; Shan H;
Transfusion; 2012 Mar; 52(3):560-6. PubMed ID: 21895674
[TBL] [Abstract][Full Text] [Related]
14. Plateletpheresis donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India.
Ojha S; Gupta AM; Nagaraju P; Poojary M; Ravatale A
Transfus Clin Biol; 2022 Feb; 29(1):65-69. PubMed ID: 34302952
[TBL] [Abstract][Full Text] [Related]
15. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
Reiss RF; Harkin R; Lessig M; Mascari J
Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
[TBL] [Abstract][Full Text] [Related]
16. Lowering the hemoglobin cutoff for female plateletpheresis donors.
Fraser JL; Whatmough A; Uhl L; Kruskall MS
Transfusion; 1998 Sep; 38(9):855-9. PubMed ID: 9738626
[TBL] [Abstract][Full Text] [Related]
17. Generation of reticulated platelets in response to whole blood donation or plateletpheresis.
Gyongyossy-Issa MI; Miranda J; Devine DV
Transfusion; 2001 Oct; 41(10):1234-40. PubMed ID: 11606821
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of ferritin, mild thrombocytosis, and increased erythropoietin are sequential events among frequent plateletpheresis donors: Implication for a ferritin screen.
Chin LT; Woon JY; Kuo SW; Lu SC
Transfus Apher Sci; 2022 Dec; 61(6):103501. PubMed ID: 35835689
[TBL] [Abstract][Full Text] [Related]
20. A questionnaire: will plateletpheresis donors accept multicomponent donation?
Qendro I; Moog R; Müller N
Transfus Apher Sci; 2002 Oct; 27(2):95-9. PubMed ID: 12350055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
